After realizing how many lupus patients had trouble keeping track of their medications, daily symptoms and appointments, an interdisciplinary team at the Hospital for Special Surgery (HSS) developed a mobile app called LupusMinder. After collecting real-world patient reports, the rheumatology, social work, and digital communications department at…
Poverty is associated with an accumulation of lupus damage, which leads to a higher risk of death, a study reports. The research, “The Relationship between Poverty and Mortality in Systemic Lupus Erythematosus,” was published in the journal Arthritis Care & Research. The link between socioeconomic…
Two specific variations in the genetic sequence of the glucocorticoid receptor — which determines how well glucocorticoid regulates metabolism and other key processes — were seen to markedly increase a person’s risk of systemic lupus erythematosus (SLE), a study conducted in China reports. Published in the International Journal of…
Patients who have their lupus treated at more than one care facility are at higher risk of developing severe infections and other diseases, a study indicates. The researchers called the tendency to go to more than one institution “fragmentation of treatment.” Their study, “Disease Outcomes and Care…
Lupus patients with certain antibodies are more prone to getting blood clots, but researchers might have come up with a way of preventing such clots from forming in the first place. In a new mouse study, researchers at the University of Michigan Medical School found that targeting the PSGL-1 molecule…
Good gut bacteria from yogurt may be able to reduce kidney inflammation in systemic lupus erythematosus patients — if results of a mouse study can be translated to humans, that is. Mice with lupus who ate lactobacillus bacteria had stronger anti-inflammatory immune reactions and less kidney disease than control mice, according…
Nimbus Therapeutics, which uses computer analysis to identify and develop therapies for autoimmune diseases like lupus, has established a long-term strategic alliance with Celgene, a company that focuses on immunology. The agreement promises to foster the development of new therapies for diseases triggered by imbalanced immune system responses. Nimbus…
Cognitive impairment is highly prevalent in patients with systemic lupus erythematosus (SLE), a study from Canada finds. The research also addressed the validity of different screening tools for this difficulty in lupus, and found the Montreal Cognitive Assessment (MoCA) may be more suitable that others. The study, “…
Patients with systemic lupus erythematosus (SLE) report high levels of satisfaction when Benlysta (belimumab) therapy was self-administered using an autoinjector, a small study reports. The study, “Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus,” was published in…
The presence of anti-SS-B autoantibodies alone was not associated with connective tissue disease (CTD) in daily clinical practice, particularly in the case of primary Sjogren’s syndrome but also lupus patients, a new study shows. The study, “Isolated positive anti-SS-B autoantibodies are not related to clinical features of…